Hinge Health Inc. shares surged to a record high of $93.37 on Wednesday, extending a rally that has pushed the stock nearly 61% higher over the past 12 months.
The digital musculoskeletal health provider’s latest quarterly results exceeded expectations, with second-quarter revenue rising 53% year-over-year to $212.8 million. Earnings per share came in at $0.59, well above the $0.13 forecast. Operating income more than doubled to $62 million, while the operating margin expanded to 29% from 19% a year ago.
The company also raised its full-year 2026 guidance following the results. Hinge Health’s market capitalization now stands at $7.25 billion, reflecting its rapid growth trajectory in the digital health sector.
Analysts at Citizens, Truist Securities, and Stifel upgraded their price targets on the stock. Citizens lifted its target to $107, maintaining a Market Outperform rating, while Truist raised its forecast to $112. Stifel set a new target of $96. The upgrades follow the company’s recent $105 million acquisition of Cylinder Health, expanding its presence into gastrointestinal health.
Hinge Health’s shares remain 1% below their 52-week high, underscoring the stock’s strong performance amid broader market volatility in the digital health space.
